TMED9 and glioblastoma: The documented correlation between TMED9 and GBM aggressiveness, coupled with the elevated TMED9 expression levels in these difficult-to-treat GSCs, prompted us to study the function and therapeutic potential of TMED9 in the GSC subpopulation.